Observational studyInvestigative ophthalmology & visual science2025
Anthropometric Measures and Fuchs' Endothelial Corneal Dystrophy: The Women's Health Initiative Observational Study.
Observational study in Investigative ophthalmology & visual science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Sex differences in congenital hereditary endothelial dystrophy (CHED) and Slc4a11Biology of sex differences · 2026Article
- Tobacco Exposure and Risk of Developing Fuchs Endothelial Corneal Dystrophy in the Women's Health Initiative Studies.Ophthalmology science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Purpose: Both genetic and environmental factors contribute to the development of Fuchs' endothelial corneal dystrophy (FECD), the most common indication for corneal transplantation in the United States. Prior studies have suggested an association of height, weight, or body mass index (BMI) with FECD. We examined the association between anthropometric measures and incident FECD in the Women's Health Initiative Observational Study (WHI-OS) of postmenopausal women (n = 22,983). Methods: Medicare Part B claims data from the WHI-OS baseline visit (1993-1998) to 2019 were used to identify incident cases of FECD. At baseline and follow-up year 3, weight, height, waist circumference (WC), and hip circumference were measured. At baseline, women were asked to recall their historic weight at ages 18, 35, and 50 years. At follow-up years 1 and 4 to 8, the women were asked to self-report their weight. Height and weight were used to calculate BMI at each time point. Adjusted hazard ratios (HRs), 95% confidence intervals (CI), and p for trend for incident FECD were estimated by measures of historic BMI, baseline anthropometrics measures, and anthropometric measures that incorporated more than one baseline visit (time-varying). Anthropometric measures were parameterized as continuous and categorical in analyses. Results: There were 1399 incident FECD cases with an annualized incidence rate of 5.06 per 1000 person-years (95% CI = 4.80-5.33) over 276,443 person-years of follow-up. No statistically significant associations were observed between baseline height and risk of FECD. Women with baseline BMIs ≥35 (obesity II) compared to <25 kg/m2 (normal weight or underweight) had lower risk of incident FECD (HR = 0.68, 95% CI = 0.53-0.88) with a P value = 0.0373 for an ordinal trend analysis across BMI categories. Significant inverse associations were observed for continuous measures of WC (HR = 0.97, 95% CI = 0.95-0.99 per 5 cm increase) and waist-to-hip ratio (WHR; HR = 0.92, 95% CI = 0.86-0.99 per 0.1 unit increase). No statistically significant associations were observed for time-varying BMI, but time-varying WC and WHR has statistically significant inverse associations with risk for FECD (data not shown). Conclusions: In this cohort of postmenopausal women, BMI, WC, and WHR were inversely associated with incident FECD. These findings generally support the potential role of anthropometric measures, particularly those indicative of abdominal obesity in FECD susceptibility in women.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.